Switch theme
Sign up to access all valuation multiples
Kose is the third-largest cosmetics company in Japan and the second in the premium segment, and is renowned for its prestige skincare brands including Decorte and Albion. The firm has been managed by the Kobayashi family since it was established in 1946. Albion, a fully consolidated subsidiary in which Kose holds a 79.5% stake, is operated independently by another branch of the Kobayashi family. The group, with a collection 37 brands/lines spanning a wide range of price points, has captured 13.6% of Japan’s premium beauty segment, according to Euromonitor. Japan remains the largest market contributing over 60% of sales, followed by North America and Europe (22%). Its distribution channels include department stores, specialty retailers, drugstores, travel retailers, and e-commerce.
1948
14.1K+
LTM Revenue $2.3B
LTM EBITDA $205M
$1.7B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
KOSE has a last 12-month revenue (LTM) of $2.3B and a last 12-month EBITDA of $205M.
In the most recent fiscal year, KOSE achieved revenue of $2.2B and an EBITDA of $203M.
KOSE expects next 12-month revenue of XXX and NTM EBITDA of XXX
See KOSE valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $2.3B | XXX | $2.2B | XXX | XXX | XXX |
| Gross Profit | $1.6B | XXX | $1.5B | XXX | XXX | XXX |
| Gross Margin | 69% | XXX | 69% | XXX | XXX | XXX |
| EBITDA | $205M | XXX | $203M | XXX | XXX | XXX |
| EBITDA Margin | 9% | XXX | 9% | XXX | XXX | XXX |
| EBIT | $129M | XXX | $119M | XXX | XXX | XXX |
| EBIT Margin | 6% | XXX | 5% | XXX | XXX | XXX |
| Net Profit | $70.4M | XXX | $51.5M | XXX | XXX | XXX |
| Net Margin | 3% | XXX | 2% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, KOSE's stock price is JPY 5789 (or $40).
KOSE has current market cap of JPY 330B (or $2.3B), and EV of JPY 242B (or $1.7B).
See KOSE trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1.7B | $2.3B | XXX | XXX | XXX | XXX | $1.23 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, KOSE has market cap of $2.3B and EV of $1.7B.
KOSE's trades at 0.8x EV/Revenue multiple, and 8.2x EV/EBITDA.
Equity research analysts estimate KOSE's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
KOSE has a P/E ratio of 32.2x.
See valuation multiples for KOSE and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $2.3B | XXX | $2.3B | XXX | XXX | XXX |
| EV (current) | $1.7B | XXX | $1.7B | XXX | XXX | XXX |
| EV/Revenue | 0.7x | XXX | 0.8x | XXX | XXX | XXX |
| EV/EBITDA | 8.1x | XXX | 8.2x | XXX | XXX | XXX |
| EV/EBIT | 12.8x | XXX | 13.9x | XXX | XXX | XXX |
| EV/Gross Profit | 1.1x | XXX | n/a | XXX | XXX | XXX |
| P/E | 32.2x | XXX | 44.0x | XXX | XXX | XXX |
| EV/FCF | -158.1x | XXX | -90.8x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialKOSE's last 12 month revenue growth is 4%
KOSE's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.
KOSE's rule of 40 is 14% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
KOSE's rule of X is 19% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for KOSE and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 4% | XXX | 4% | XXX | XXX | XXX |
| EBITDA Margin | 9% | XXX | 9% | XXX | XXX | XXX |
| EBITDA Growth | 15% | XXX | 4% | XXX | XXX | XXX |
| Rule of 40 | 14% | XXX | 13% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 19% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.2M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 24% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 64% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Acme United | XXX | XXX | XXX | XXX | XXX | XXX |
| EZZ Life Science | XXX | XXX | XXX | XXX | XXX | XXX |
| Live Verdure | XXX | XXX | XXX | XXX | XXX | XXX |
| Lavipharm | XXX | XXX | XXX | XXX | XXX | XXX |
| Sarantis Group | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
KOSE acquired XXX companies to date.
Last acquisition by KOSE was XXXXXXXX, XXXXX XXXXX XXXXXX . KOSE acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was KOSE founded? | KOSE was founded in 1948. |
| Where is KOSE headquartered? | KOSE is headquartered in Japan. |
| How many employees does KOSE have? | As of today, KOSE has 14.1K+ employees. |
| Is KOSE publicy listed? | Yes, KOSE is a public company listed on TKS. |
| What is the stock symbol of KOSE? | KOSE trades under 4922 ticker. |
| When did KOSE go public? | KOSE went public in 2000. |
| Who are competitors of KOSE? | Similar companies to KOSE include e.g. Acme United, EZZ Life Science, Live Verdure, Lavipharm. |
| What is the current market cap of KOSE? | KOSE's current market cap is $2.3B |
| What is the current revenue of KOSE? | KOSE's last 12 months revenue is $2.3B. |
| What is the current revenue growth of KOSE? | KOSE revenue growth (NTM/LTM) is 4%. |
| What is the current EV/Revenue multiple of KOSE? | Current revenue multiple of KOSE is 0.7x. |
| Is KOSE profitable? | Yes, KOSE is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of KOSE? | KOSE's last 12 months EBITDA is $205M. |
| What is KOSE's EBITDA margin? | KOSE's last 12 months EBITDA margin is 9%. |
| What is the current EV/EBITDA multiple of KOSE? | Current EBITDA multiple of KOSE is 8.1x. |
| What is the current FCF of KOSE? | KOSE's last 12 months FCF is -$10.5M. |
| What is KOSE's FCF margin? | KOSE's last 12 months FCF margin is 0%. |
| What is the current EV/FCF multiple of KOSE? | Current FCF multiple of KOSE is -158.1x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
